Statement on injectable contraception.
D000830:Animals, Laboratory; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D004194:Disease; D016889:Endometrial Neoplasms; D005193:Family Planning Services; D007267:Injections; D007390:International Agencies; D007774:Lactation; D017258:Medroxyprogesterone Acetate; D008599:Menstruation Disturbances; D009369:Neoplasms; D009640:Norethindrone; D009938:Organizations; D012106:Research; D013256:Steroids; D002583:Uterine Cervical Neoplasms
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D013256:Steroids; D017258:Medroxyprogesterone Acetate; D009640:Norethindrone
Animals, Laboratory; Cancer; Cervical Cancer; Clinical Research; Contraception; Contraceptive Agents, Female; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents--administraction and dosage; Contraceptive Methods--side effects; Diseases; Endometrial Cancer; Family Planning; Injectables--side effects; International Agencies; Ippf; Lactation; Medroxyprogesterone Acetate--administraction and dosage; Menstruation Disorders; Neoplasms; Norethindrone Enanthate--administraction and dosage; Norethindrone--administraction and dosage; Organizations; Research Methodology; Steroid Metabolic Effects